Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Farah A. Alshammari"'
Autor:
Maad F. Al-Saati, Sadiq I. Alaqaili, Farah A. Alshammari, Mohamed A. N. ElRaei, Alia A. Albaiz, Daniel Tushinski, Omar A. Al-Mohrej
Publikováno v:
BMC Musculoskeletal Disorders, Vol 24, Iss 1, Pp 1-6 (2023)
Abstract Background Continuous local infiltration analgesia (CLIA) can be administered via intraarticular or periarticular techniques in patients undergoing total knee arthroplasty (TKA). The purpose of this investigation was to retrospectively repor
Externí odkaz:
https://doaj.org/article/0c057fc286d94fb79bb3fd4984cbeca1
Autor:
Sondas Alsharidah, Mariam Ayed, Reem M. Ameen, Fatma Alhuraish, Najat A. Rouheldeen, Farah R. Alshammari, Alia Embaireeg, Mariam Almelahi, Maitham Adel, Mohammed E. Dawoud, Mohammad A. Aljasmi, Nashmi Alshammari, Abdullah Alsaeedi, Wasel Al-Adsani, Hussan Arian, Husain Awad, Humoud A. Alenezi, Azeez Alzafiri, Enas F. Gouda, Mohammad Almehanna, Salem Alqahtani, Abdulrahman Alshammari, Medhat Z. Askar
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 439-446 (2021)
Objective: To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for patients with moderate and severe COVID-19 disease. Methods: This non-randomized prospective cohort study was conducted from May 21 to June 30, 2020, at four majo
Externí odkaz:
https://doaj.org/article/6f0e56e510e141aba25350a63a725290
Autor:
LAMA GHASSAN ABDULLAH, AHMAD IBRAHIM ABALKHAIL, DAFER ABDULRHMAN DAFER ALSHEHRI, ZAINAB ABDULMOHSEN ALMUALLEM, ABLAA MUBARAK OBAID ALKORBI, SHROOG KHASHMAN ALSHAMMARI, ABEER ALI M ALSUBHI, MOHAMMED KHALID ALGHAMDI, ALI ABDULAZEEM HABEEB, ABDULLAH MOHAMMED ALWADAI, ALI HASSAN ALBAYAT, NUJUD MOHAMMED ALKHERAIJI, SARAH MOHAMMED M ALJAZAERY, FARAH NAJEH ALSHAMMARI, NISREEN OMAR ASRAF
Publikováno v:
UTTAR PRADESH JOURNAL OF ZOOLOGY. :350-354
According to one definition, Family Medicine is a specialty that provides the provision of ongoing, comprehensive medical treatment to patients within the setting of their families and communities. Acute and chronic care, identification of family and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42dd3c86263c6a0472b99e2711994604
https://doi.org/10.56557/upjoz/2022/v43i243330
https://doi.org/10.56557/upjoz/2022/v43i243330
Autor:
Yassir Mohammed Darwish, Abdulelah Abdulrhman Najmi, E. Alhazmi, Essa Ibrahim, S. Alsanna, Haytham Bager, Sakinah Jawad Al Kuwaiti, Hozan Mohammed Ali, Khalid Ali Alsaykhan, Farah Najeh ALShammari, Sarh Sami Abdulghani, N. Alomrani, Nawaf Farag, Arishi, M. Khaled Yahya, Basel Ali S. Alqahtani, Khalifah Sulaiman Alsuqayh, Hajar Saleh Alnajdi, Faisal Suliman Algaows
Publikováno v:
Journal of Pharmaceutical Research International. :1600-1606
Individual survival would be impossible without anxiety, which is a natural and important emotion. Anxiety is considered a disease that requires treatment when it occurs in the absence of a threat, or in a disproportionate proportion to a threat, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3a92c7e4c8e1c453b493bc71c541bfb
https://doi.org/10.9734/jpri/2021/v33i60b34783
https://doi.org/10.9734/jpri/2021/v33i60b34783
Autor:
Rawan A. Al-Shamali, Yaser Ali, Wasl Al-Adsani, Maryam Al-Melahi, Farah R. Alshammari, Yousef Al-Shamali, Ahmad Alsaber
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0254379 (2021)
PLoS ONE
PLoS ONE
PurposeThis cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in three of Kuwait’s largest public
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cae80a4431353116bbcaed0644d856c
https://strathprints.strath.ac.uk/77450/7/Al_Shamali_etal_PONE_2021_tocilizumab_for_the_treatment_of_severe_COVID_19_pneumonia.pdf
https://strathprints.strath.ac.uk/77450/7/Al_Shamali_etal_PONE_2021_tocilizumab_for_the_treatment_of_severe_COVID_19_pneumonia.pdf
Autor:
Nashmi Alshammari, Azeez Alzafiri, Abdulrahman Alshammari, Alia Embaireeg, Najat A. Rouheldeen, Mariam Ayed, Sondas Ibrahim Alsharidah, Fatma Alhuraish, Salem Alqahtani, Abdullah Alsaeedi, Farah R. Alshammari, Enas F. Gouda, Reem Ameen, Mohammad A. Aljasmi, Maitham Adel, Mohammad Almehanna, Medhat Askar, Husain Awad, Humoud A. Alenezi, Mohammed E. Dawoud, Hussan Arian, Wasel Al-Adsani, Mariam Almelahi
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 103, Iss, Pp 439-446 (2021)
International Journal of Infectious Diseases, Vol 103, Iss, Pp 439-446 (2021)
Highlights • Convalescent plasma is adjunct treatment in COVID-19 moderate and severe disease. • Clinical improvement is noticed in COVID-19 disease after convalescent plasma. • Mortality is significantly reduced after COVID-19 convalescent pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7ffe4bddd44c62c92f9a9c287a7c43
Autor:
Mariam Almelahi, Mohammed E. Dawoud, Abdulrahman Alshammari, Salem Alqahtani, Mariam Ayed, Mohammad Almehanna, Najat A. Rouheldeen, Humoud A. Alenezi, Medhat Askar, Farah R. Alshammari, Reem Ameen, Mohammad A. Aljasmi, Abdullah Alsaeedi, Azeez Alzafiri, Maitham Adel, Enas F. Gouda, Husain Awad, Nashmi Alshammari, Alia Embaireeg, Sondas Ibrahim Alsharidah, Fatma Alhuraish, Wasel Al-Adsani, Hussain Arian
Publikováno v:
SSRN Electronic Journal.
Background: The transfusion of COVID-19 convalescent plasma (CCP) is being considered to improve clinical outcomes in patients with COVID-19 disease. We investigated the effectiveness of CCP therapy in patients withmoderate and severe COVID-19 diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ebb85078bf327aa22f7c1f1ee9efbb2
https://doi.org/10.2139/ssrn.3685932
https://doi.org/10.2139/ssrn.3685932